Navigation Links
Verenium Launches Second Enzyme Product for Oilfield Services
Date:1/5/2012

SAN DIEGO, Jan. 5, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced the introduction of VEREFLOW™ alpha-amylase, a unique enzyme for the removal of filter cake in drilling operations.  This high performance enzyme effectively removes filter cake that acts as a barrier to hydrocarbon flow on the face of the wellbore, the hole drilled in the creation of a well.  Effective over a wide temperature and pH range and with a safer environmental footprint compared to traditional chemicals often used in the process, VEREFLOW™ alpha-amylase provides the oilfield services industry greater operational flexibility. 

 

"We are pleased to be expanding our offering in the oilfield services market to offer another high-performance enzyme product with a superior environmental profile – a key advantage to operators in this industry," said James Levine, President and Chief Executive Officer at Verenium. 

 

Verenium estimates the addressable global market for VEREFLOW™ alpha-amylase in the United States to be approximately $20 million annually. The Company began marketing and selling VEREFLOW™ alpha-amylase in the first quarter of 2012 and manufactures the enzyme under its agreement with Fermic S.A. de C.V in Mexico City.

 

 

About VEREFLOW™ Alpha-Amylase

VEREFLOW™ alpha-amylase is a high performance enzyme designed to break down filter-cake created by water-based mud containing starch and other polymers used in drilling operations. VEREFLOW™ alpha-amylase has been shown to be effective over an exceptionally wide temperature and pH range providing greater operational flexibility without a loss in productivity t
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Verenium to Host Analyst and Investor Day
2. Verenium Reports Financial Results for the First Quarter Ended March 31, 2011
3. Verenium Corporation to Announce First Quarter 2011 Financial Results
4. Verenium Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2010
5. Verenium Announces Changes in Senior Management
6. Verenium Announces 2010 Business Update and Outlook for 2011
7. Successful Diabetes Product Launches Balance Digital & Traditional Public Relations Tools
8. Actavis Launches Generic Equivalent of Ritalin LA® in the US, With 180-Day Exclusivity
9. theVisualMD Launches a Revolutionary New Visual Path to Wellness
10. Mylan Launches First Generic Version of Teveten® Tablets
11. Doximity Launches ExpertFinder to Match Clinical Need with Clinical Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... will participate in the Deutsche Bank Health Care Conference ... Waterfront Hotel.  Mr. Adrian Adams , ... an overview of the Company and its product pipeline ...   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/23/2013)... 3SBio Inc. (NASDAQ: SSRX ... China -based biotechnology company focused on ... today that, at an extraordinary general meeting held ... favor of the proposal to authorize and approve ... dated February 8, 2013, among Decade Sunshine Limited, ...
(Date:5/23/2013)... , May 23, 2013  Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The Deutsche ... Boston, MA on May 29, 2013 ... ) The public may access Mr. Lindop,s ... About Haemonetics Haemonetics (NYSE: HAE ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 43SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... * Statistically significant reduction in sedation during ... * Statistically significant reduction in nausea in ... Cambridge, UK, 8th June 2007 - CeNeS ... company, announces,additional data from post-hoc analysis of ...
... Ala.--(BUSINESS WIRE)--Jun 8, 2007 - ProEthic,Pharmaceuticals, Inc., ... develops, licenses, and markets niche,prescription products, today ... the Company's product candidate for the treatment,of ... two poster,presentations at the American Headache Society's ...
Cached Medicine Technology:Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting 2ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting 3ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting 4
(Date:5/25/2013)... The current residents of Back2Basics - Long Term Drug and ... came together Saturday, May 18th to celebrate the company's 3rd ... residents got up to thank Roy Duprez, CEO and Founder ... recovery, and giving them a second chance at life. , ... realizing the need for a long-term facility. What started ...
(Date:5/24/2013)... 25, 2013 The special 35% off ... products from Sublime Beauty®. The products include a ... and many of the ingredients are in fact organic. ... is dreaded by many women," says Kathy Heshelow, founder ... women can diminish their cellulite." The plan includes two ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 ShopPharmacyCounter.com PhenObestin ... experts ShopPharmacyCounter.com have announced price reductions on their popular ... store, which helps clients to lose weight as effortlessly ... PhenObestin 37.5 by more than 50%. , Bottles have ... limited time and all orders will receive free shipping. ...
(Date:5/24/2013)... This week is National EMS Week, which recognizes ... the best emergency care and to improve health communications ... to educate the public that all can play a ... first link, and a very important one. According to ... cardiac arrest can triple a victim’s chance of survival. ...
(Date:5/24/2013)... 2013 ResortQuest Real Estate® is proud ... Feher team at the firm’s Bethany Beach location. , ... her home in 1975. Her real estate career began ... aspects of the real estate business - receptionist, cleaning ... years, a licensed sales associate. , “I am ...
Breaking Medicine News(10 mins):Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:"Get Ready for Summer Sale" at Sublime Beauty® Continues: New Cellulite Whisperer® Products 2Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2
... grant from the Agency for Healthcare Research and Quality ... the comparative effectiveness of positron emission tomography (PET) and ... on the diagnosis and management of cancer patients, but ... , "Comparative effectiveness research is essential to the future ...
... Intacs ... provided by Khanna institute in Beverly Hills , ... (Vocus) April 13, 2010 -- Khanna Institute, which expanded into Beverly Hills, ... that it is offering its Beverly Hills patients the opportunity to obtain a product known ...
... ... Videoconferencing System at the National Association of Broadcasters (NAB) show in Las ... lower price point than existing systems. Espresso HD uses patented next-generation ... ultra-fast set up and installation, better visual performance than competitive solutions using ...
... most of the brain tumor can often be removed surgically, ... this is that sporadic, infiltrative tumor cells will remain in ... University of Bonn have now subjected these ,forgotten, cells to ... were able to show that many of the fundamental properties ...
... , PHILADELPHIA Molecular biologist Jonathan Brody, Ph.D., assistant ... Thomas Jefferson University, has been awarded a 2010 Pancreatic ... (AACR) Career Development Award in memory of Skip Viragh. ... to help support his innovative research in pancreatic cancer. ...
... ... 80% of Women Enjoy Reading or Viewing Pornography; 73% Wish They Were Having More Sex. ... San Francisco, CA (PRWEB) April 13, 2010 ... a copy of What Women Really Want in Bed: The Surprising Secrets Women Wish Men ...
Cached Medicine News:Health News:SNM receives grant from AHRQ for comparative effectiveness research 2Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 2Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 3Health News:HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions 2Health News:HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions 3Health News:HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions 4Health News:Brain cancer: Study focuses on forgotten cells 2Health News:Jefferson researcher receives 2010 Pancreatic Cancer Action Network-AACR Career Development Award 2Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 2Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 3Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 4
Intended for the quantitative determination of uric acid in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 20 mg/dL (1190 mol/L). Single vial, dry powder reagent....
The Mikro 20 line of centrifuges has 4 models for microlitre applications complete with rotor. Whether cryo, PCR or standard micro tubes, it is the appropriate centrifuge of choice with angle rotor....
... Engineered for small and medium volume laboratories, ... 1010 System offers the speed, simplicity and ... requirements. Compact yet powerful, the Elecsys 1010 ... rapid response assays to routine testing without ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: